Jing Hu

7PUBLICATIONS
72CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 08, 2026
ZNF711 promotes enzalutamide resistance through transcriptional and epigenetic modification of the androgen receptor signaling pathway.

Ping Liu, Baozhen Wang, Hui Liu

|Jan 30, 2026
Targeting PKMYT1 enhances antitumor immune responses to PD-L1 blockade in castration-resistant prostate cancer.

Lin Gao, Baozhen Wang, Hui Liu

|Jan 30, 2026
FOSL2 Regulates PD-L1 and Modulates Hormone Therapy Response Heterogeneity.

Feifei Sun, Baozhen Wang, Shuyu Mei

|Oct 01, 2025
SOX4-Mediated Post-transcriptional Suppression of PTEN via miR-106b∼25 Cluster Contributes to Prostate Cancer Aggressiveness.

Feifei Sun, Lin Gao, Meng Wang

|Aug 18, 2025
Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration-Resistant Prostate Cancer.

Noshad Hosseini, Rahul Mannan, Ryan J Rebernick

|Apr 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer.

Caleb Cheng, Jing Hu, Rahul Mannan

Pageof 2

Frequent Collaborators

4 joint publications

Bo Han

4 joint publications

Feifei Sun

4 joint publications

Baozhen Wang

4 joint publications

Lin Gao